Guardian Health
First malaria drug for babies is approved in ‘major public health milestone’
WHO has granted prequalification to Coartem Baby, the first malaria treatment specifically formulated for newborns and infants — a population that previously had no safe dedicated medication. The approval is especially significant for sub-Saharan Africa, where up to 18% of children under six months contract the disease. With 610,000 malaria deaths recorded in 2024, the move could meaningfully reduce a death toll that falls disproportionately on the youngest and most vulnerable patients.
Read article →Medical Xpress
Medicaid restrictions could lead to over 1 million missed cancer screenings
Proposed Medicaid cuts could result in more than one million Americans missing critical cancer screenings annually, according to a new research letter published in JAMA Oncology. The University of Chicago Medicine analysis warns that changes to federal eligibility rules would strip coverage from low-income patients who disproportionately rely on Medicaid for preventive care. Delayed diagnoses typically mean later-stage cancers, higher treatment costs, and significantly worse survival rates.
Read article →Medical Xpress
Lithium not working? Large-scale study highlights favorable treatment strategies for bipolar disorder
Lithium remains a cornerstone treatment for bipolar disorder, but a new large-scale study identifies alternative strategies for patients who don't respond to it. The findings carry significant weight given that bipolar disorder affects up to 3% of the global population. For clinicians, clearer guidance on next-step treatments could meaningfully improve outcomes for millions of patients worldwide.
Read article →Medical Xpress
FDA approves once-daily Idvynso tablet for treating HIV
The FDA has approved Merck's Idvynso, a once-daily two-drug tablet combining doravirine and islatravir for HIV-1 treatment in adults who are already virologically suppressed. The approval marks a significant step in HIV therapy simplification, offering eligible patients a streamlined regimen with fewer active ingredients than many current standards of care. For the millions managing HIV long-term, reduced pill burden and dosing complexity can meaningfully improve adherence and quality of life.
Read article →
Stat News
Federal appeals court blocks mailing of abortion pill mifepristone
A federal appeals court has moved to block the mailing of mifepristone, forcing the abortion pill to be dispensed only in person at clinics. The ruling represents a significant blow to abortion access, particularly for patients in states with limited clinic availability. Given that mifepristone is used in the majority of U.S. abortions, the decision could have sweeping consequences for reproductive healthcare nationwide.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →